logo munafa.org.in

NEWS Gainers Losers
 Learn then Earn

 story : Seres shares fall 55% after the company says its colitis drug failed in mid-stage clinical trial #FinanceUSA #StockMarketNEWS Shares of Seres Therapeutics Inc. tumbled 55.4% in premarket trading on

@stockMarketNEWS 9 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

Seres shares fall 55% after the company says its colitis drug failed in mid-stage clinical trial #FinanceUSA #StockMarketNEWS
Shares of Seres Therapeutics Inc. tumbled 55.4% in premarket trading on Thursday after the company said a mid-stage study testing its experimental ulcerative colitis drug failed. As a result, Seres closed the open-label and maintenance part of the trial. Seres' stock is down 15.0% so far this year, while the S&P 500 has gained 15.1%.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme